Amedeo's Top 20

Amedeo Smart

Independent Medical Education

11 April 2016

Multidisciplinary Journal Club

  1. Di Biase L, Mohanty P, Mohanty S, Santangeli P, et al.
    Ablation vs. Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
    Circulation 2016.

  1. Appiah GD, Blanton L, D'Mello T, Kniss K, et al.
    Influenza Activity - United States, 2014-15 Season and Composition of the 2015-16 Influenza Vaccine.
    MMWR Morb Mortal Wkly Rep 2015;64:583-590.

  2. Hosseinipour MC, Bisson GP, Miyahara S, Sun X, et al.
    Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Lancet 2016;387:1198-209.

  3. Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, et al.
    A blood RNA signature for tuberculosis disease risk: a prospective cohort study.
    Lancet 2016.

  4. Solomon BJ, Cappuzzo F, Felip E, Blackhall FH, et al.
    Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014.
    J Clin Oncol 2016.

  1. Glass J, Won M, Schultz CJ, Brat D, et al.
    Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.
    J Clin Oncol 2016.

  2. Del Trigo M, Bergeron S, Bernier M, Amat-Santos IJ, et al.
    Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study.
    Lancet 2016;387:1290-7.

  3. Hasenfuss G, Hayward C, Burkhoff D, Silvestry FE, et al.
    A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
    Lancet 2016;387:1298-304.

  4. Plowden TC, Schisterman EF, Sjaarda LA, Zarek SM, et al.
    Subclinical hypothyroidism and thyroid autoimmunity are not associated with fecundity, pregnancy loss or live birth.
    J Clin Endocrinol Metab 2016.

  5. Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P, et al.
    Pathological alpha-synuclein in gastrointestinal tissues from prodromal parkinson's disease patients.
    Ann Neurol 2016.

  1. Fossa SD, Wiklund F, Klepp O, Angelsen A, et al.
    Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of Th
    Eur Urol 2016.

  2. Bell K, Hayen A, Glasziou P, Irwig L, et al.
    Relative Utility of BMD and Bone Turnover Monitoring of Zoledronic Acid Therapy among Women with Osteoporosis: Secondary Analysis of Randomised Controlled Trial Data.
    J Bone Miner Res 2016.

  3. Co JL, Mejia MB, Que JC, Dizon JM, et al.
    Effectiveness of honey on radiation-induced oral mucositis, time to mucositis, weight loss, and treatment interruptions among patients with head and neck malignancies: A meta-analysis and systematic review of literature.
    Head Neck 2016.

  4. Ribi K, Luo W, Bernhard J, Francis PA, et al.
    Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.
    J Clin Oncol 2016.

  5. Pitter KL, Tamagno I, Alikhanyan K, Hosni-Ahmed A, et al.
    Corticosteroids compromise survival in glioblastoma.
    Brain 2016.

  1. Momesso DP, Vaisman F, Yang SP, Bulzico DA, et al.
    J Clin Endocrinol Metab 2016.

  2. Bellon JA, Conejo-Ceron S, Moreno-Peral P, King M, et al.
    Intervention to Prevent Major Depression in Primary Care: A Cluster Randomized Trial.
    Ann Intern Med 2016.

  3. Lee S, Viqar F, Zimmerman ME, Narkhede A, et al.
    White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the Dominantly Inherited Alzheimer Network.
    Ann Neurol 2016.

  4. Brigliadori G, Foca F, Dall'Agata M, Rengucci C, et al.
    Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma.
    J Neurooncol 2016.

  5. Allard MA, Sebagh M, Ruiz A, Guettier C, et al.
    Does Pathological Response for Hepatocellular Carcinoma in Patients with Cirrhosis Predict Outcome after Liver Resection or Transplantation?
    J Hepatol 2015.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016